abstract |
The present invention provides compounds of formula (I), wherein R 1 , R 3 , R 4 , R 5 , R 6 , R 7 , L, X and Y are as defined in the description; methods and intermediates for their preparation, containing Their pharmaceutical compositions and their use in therapy. The compounds are inhibitors of human neutrophil elastase. |